Fosun Pharmaceutical Buys Back Nearly 3 Million Yuan Worth of Shares

MT NewswiresDec 13 05:30 ET

On December 13, FOSUN PHARMA (02196.HK) spent HKD 2.6635 million to repurchase 0.1855 million shares.

Gelonghui reported on December 13 that FOSUN PHARMA (02196.HK) announced that on December 13, 2024, it would spend 2.6635 million Hong Kong dollars to repurchase 0.1855 million shares, with a repurchase price per share ranging from 14.3 to 14.46 Hong Kong dollars.

Gelonghui FinanceDec 13 04:31 ET

Fosun Pharma Boosts Equity in Key Funds

TipRanksDec 11 08:09 ET

Express News | Shanghai Fosun Pharma - Ningbo Fuying Will Acquire Equity Interests of RMB200.00 of Fund

ReutersDec 11 07:51 ET

Shanghai Fosun Pharma's New Strategic Agreements With Fosun International

TipRanksDec 11 06:39 ET

FOSUN PHARMA (600196.SH): The controlling subsidiary intends to increase its shareholding in the Fund.

On December 11, Gelonghui reported that FOSUN PHARMA (600196.SH) announced that its holding subsidiary Ningbo Fuying, as an LP of the Nanjing Fund, Dalian Star Future Fund, and Suzhou Angel Fund, signed transfer agreements with FOSUN High Technology regarding the Shareholding of several property interests in these funds. The total consideration for this Shareholding is 140.42 million yuan, which includes: (1) a proposed investment of 90.92 million yuan to acquire another LP share of the Nanjing Fund, for which FOSUN High Technology has already contributed 200 million yuan, accounting for about 25.09% of the total contributed amount of this fund (of which 11 million yuan has been paid in).

Gelonghui FinanceDec 11 03:38 ET